Related Experiment Video

Updated: Aug 16, 2025

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells
12:43

Generation of a Novel Dendritic-cell Vaccine Using Melanoma and Squamous Cancer Stem Cells

Published on: January 6, 2014

11.9K

DNA Vaccines to Improve Immunogenicity and Effectiveness in Cancer Vaccinations: Advancement and Developments

Arun Kumar Singh1, Rishabha Malviya1

  • 1Department of Pharmacy, School of Medical and Allied Sciences, Galgotias University, Greater Noida, Uttar Pradesh, India.

Current Gene Therapy
|December 20, 2022
PubMed

Insights

DNA vaccines offer a promising approach to cancer immunotherapy by stimulating antigen-specific immune responses. This study explores their immunogenicity and efficacy for cancer treatment.

Area of Science:

  • Oncology
  • Immunology
  • Biotechnology

Background:

  • DNA vaccines represent a novel and promising strategy for cancer treatment.
  • They function by delivering tumor antigen genes to the immune system to elicit antigen-specific immune responses as part of cancer immunotherapy.
  • Enhancements in delivery, composition, prime-boost protocols, and checkpoint inhibition can significantly improve vaccine efficacy.

Purpose of the Study:

  • To examine the immunogenicity and efficacy of DNA vaccines for cancer immunotherapy.
  • To explore strategies for overcoming self-tolerance to tumor antigens.
  • To assess the potential of DNA vaccine technology in both preventative and therapeutic cancer vaccination.

Main Methods:

  • Review of current DNA vaccine strategies for cancer immunotherapy.
  • Analysis of methods to enhance vaccine efficacy, including novel delivery routes and immunomodulatory agents.
  • Investigation of approaches to overcome tumor antigen self-tolerance through adaptive immune system modulation and vaccine design.

Main Results:

  • DNA vaccines are capable of triggering and strengthening antigen-specific immune responses against tumors.
  • Various strategies, such as improved delivery and combination therapies, show potential for increasing vaccine effectiveness.
  • Overcoming self-tolerance is achievable through combined adaptive immunity and vaccine design approaches.

Conclusions:

  • DNA vaccines hold significant promise as a creative method for cancer treatment and immunotherapy.
  • Further development and clinical investigation are warranted to optimize their immunogenicity and efficacy.
  • The technology is advancing for both preventative and therapeutic applications in cancer immunotherapy.
Keywords:
DNA vaccineGene therapyTAAscancer treatmentimmunogenicvaccine

More Related Videos

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine09:15

Experimental Melanoma Immunotherapy Model Using Tumor Vaccination with a Hematopoietic Cytokine

Published on: February 24, 2023

3.5K
Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo12:42

Paramyxoviruses for Tumor-targeted Immunomodulation: Design and Evaluation Ex Vivo

Published on: January 7, 2019

9.6K

Related Concept Videos

Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
478
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
624
Vaccinations01:51

Vaccinations

Overview
45.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.9K
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.0K